Immunohistochemistry-Based Molecular Classification of Muscle-Invasive Bladder Urothelial Carcinoma: Survival Trends Across Molecular Subtypes
Muscle-invasive bladder urothelial carcinoma (MIBUC) is a heterogeneous disease, presenting variable clinical outcomes and therapeutic responses. Although molecular classification provides important prognostic information, its clinical use is limited by cost and technical complexity, making immunohistochemistry (IHC) a...